Back
Day Range
$2.34
$2.34
52-Week Range
$2.14
$2.88
Volume
300
50D / 200D Avg
$2.26
/
$2.31
Prev Close
$2.34
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.0 | 0.4 |
| P/B | 0.2 | 2.9 |
| ROE % | 7.9 | 3.8 |
| Net Margin % | 3.9 | 3.9 |
| Rev Growth 5Y % | 2.3 | 10.0 |
| D/E | 0.6 | 0.2 |
Key Takeaways
Revenue grew 2.25% annually over 5 years — modest growth
Negative free cash flow of -954.41M
P/E of 2.04 — trading at a low valuation
Capital efficient — spends only 1.60% of revenue on capex
ROIC of 3.87% — low return on invested capital
Growth
Revenue Growth (5Y)
2.25%
Revenue (1Y)0.61%
Earnings (1Y)2.49%
FCF Growth (3Y)N/A
Quality
Return on Equity
7.89%
ROIC3.87%
Net Margin3.85%
Op. Margin4.01%
Safety
Debt / Equity
0.55
Current Ratio1.57
Interest Coverage7.26
Valuation
P/E Ratio
2.04
P/B Ratio0.16
EV/EBITDA3.87
Dividend Yield0.05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.61% | Revenue Growth (3Y) | -0.05% |
| Earnings Growth (1Y) | 2.49% | Earnings Growth (3Y) | -15.35% |
| Revenue Growth (5Y) | 2.25% | Earnings Growth (5Y) | -5.99% |
| Profitability | |||
| Revenue (TTM) | 75.45B | Net Income (TTM) | 2.91B |
| ROE | 7.89% | ROA | 3.44% |
| Gross Margin | 15.18% | Operating Margin | 4.01% |
| Net Margin | 3.85% | Free Cash Flow (TTM) | -954.41M |
| ROIC | 3.87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.55 | Current Ratio | 1.57 |
| Interest Coverage | 7.26 | Dividend Yield | 0.05% |
| Valuation | |||
| P/E Ratio | 2.04 | P/B Ratio | 0.16 |
| P/S Ratio | 0.08 | PEG Ratio | 1.82 |
| EV/EBITDA | 3.87 | Dividend Yield | 0.05% |
| Market Cap | 5.93B | Enterprise Value | 11.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75.45B | 74.99B | 75.52B | 70.79B | 69.01B |
| Net Income | 2.91B | 2.84B | 4.06B | 3.97B | 3.72B |
| EPS (Diluted) | 1.82 | 1.74 | 2.49 | 2.44 | 2.29 |
| Gross Profit | 11.46B | 12.52B | 14.19B | 13.28B | 13.23B |
| Operating Income | 3.02B | 3.60B | 5.12B | 5.07B | 4.79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 84.55B | 81.68B | 78.59B | 74.67B | 66.12B |
| Total Liabilities | 43.41B | 43.91B | 41.91B | 41.03B | 34.79B |
| Shareholders' Equity | 37.81B | 35.90B | 34.92B | 32.07B | 29.06B |
| Total Debt | 20.70B | 12.37B | 11.70B | 11.43B | 9.92B |
| Cash & Equivalents | 14.95B | 18.27B | 21.31B | 22.50B | 22.38B |
| Current Assets | 61.55B | 57.76B | 55.98B | 57.06B | 52.81B |
| Current Liabilities | 39.14B | 38.92B | 36.24B | 37.40B | 32.25B |